ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks”

May 13, 1988

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992